An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development

被引：0
|
作者：
Shubham Upadhayay
Narhari Gangaram Yedke
Vikrant Rahi
Surbhi Singh
Sachin Kumar
Anchal Arora
Priyanka Chandolia
Prabhsharan Kaur
Mandeep Kumar
Prashant Koshal
Sumit Jamwal
Puneet Kumar
机构：
[1] Central University of Punjab,Department of Pharmacology
[2] Punjab College of Technical Education,Department of Pharmaceutical Sciences
[3] Maharaja Ranjit Singh Punjab Technical University,Department of Pharmaceutical Sciences & Technology
[4] Department of Pharmacology,Department of Science
[5] All India Institute of Medical Sciences,Department of Psychiatry
[6] Department of Pharmacology,undefined
[7] ISF College of Pharmacy,undefined
[8] University of Basilicata,undefined
[9] Yale University School of Medicine,undefined
来源：
Neurochemical Research | 2023年 / 48卷
关键词：
3-Nitropropionic acid (3-NPA); Mitochondrial Dysfunction; Excitotoxicity; Animal Model; Neurodegeneration; Huntington’s Disorder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1631 / 1647
页数：16
相关论文
共 22 条
  • [1] An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development
    Upadhayay, Shubham
    Yedke, Narhari Gangaram
    Rahi, Vikrant
    Singh, Surbhi
    Kumar, Sachin
    Arora, Anchal
    Chandolia, Priyanka
    Kaur, Prabhsharan
    Kumar, Mandeep
    Koshal, Prashant
    Jamwal, Sumit
    Kumar, Puneet
    NEUROCHEMICAL RESEARCH, 2023, 48 (06) : 1631 - 1647
  • [2] 3-nitropropionic acid animal model and Huntington's disease
    Borlongan, CV
    Koutouzis, TK
    Sanberg, PR
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (03) : 289 - 293
  • [3] MODEL OF HUNTINGTON'S DISEASE INDUCED WITH 3-NITROPROPIONIC ACID
    Tunez, I.
    Santamaria, A.
    REVISTA DE NEUROLOGIA, 2009, 48 (08) : 430 - 434
  • [4] Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease
    Park, Juno-Eun
    Lee, Soon-Tae
    Im, Woo-Seok
    Chu, Kon
    Kim, Manho
    NEUROSCIENCE LETTERS, 2008, 448 (01) : 143 - 147
  • [5] Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation
    Borlongan, CV
    Nishino, H
    Sanberg, PR
    NEUROSCIENCE RESEARCH, 1997, 28 (03) : 185 - 189
  • [6] Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington's disease
    Sandhir, Rajat
    Mehrotra, Arpit
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (03): : 421 - 430
  • [7] Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study
    Kumar, Puneet
    Kalonia, Harikesh
    Kumar, Anil
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (10) : 1399 - 1411
  • [8] Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease
    Chakraborty, J.
    Nthenge-Ngumbau, D. N.
    Rajamma, U.
    Mohanakumar, K. P.
    BEHAVIOURAL BRAIN RESEARCH, 2014, 264 : 91 - 104
  • [9] Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease
    Napolitano, Maddalena
    Costa, Loredana
    Palermo, Rocco
    Giovenco, Alessandro
    Vacca, Alessandra
    Gulino, Alberto
    BRAIN RESEARCH BULLETIN, 2011, 85 (3-4) : 231 - 237
  • [10] Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats
    Wells, Russell G.
    Azzam, Azzam F.
    Hiller, Amie L.
    Sardinia, Michael F.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (01) : 55 - 66
123